We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · November 25, 2016

Ticagrelor Not Superior to Clopidogrel for the Reduction of Cardiovascular Events in PAD

The New England Journal of Medicine

 

Additional Info

The New England Journal of Medicine
Ticagrelor Versus Clopidogrel in Symptomatic Peripheral Artery Disease
N. Engl. J. Med 2016 Nov 13;[EPub Ahead of Print], WR Hiatt, FGR Fowkes, G Heizer, JS Berger, I Baumgartner, P Held, BG Katona, KW Mahaffey, L Norgren, WS Jones, J Blomster, M Millegård, C Reist, MR Patel

Further Reading